🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

On Demand Now! C-Path's TRxA unveiled the 2025 global Request for Proposals webinar. TRxA has merged its efforts to support both biologics and small molecule therapeutics under a single, unified RFP.  Watch here: f.mtr.cool/mjezwmpgdj

Join us for eCOA Exchange #4, the next offering in the eCOA Consortium’s eCOA Educational Series entitled eCOA: The Measure Owner's Perspective!  Register here: f.mtr.cool/gwlvzqpjnm  📆 Tuesday May 6, 2025 ⏰ 11 - 11:55 a.m. Eastern (US)

SAVE THE DATE! 2025 C-Path Global Impact Conference (CGIC), scheduled for September 9-11, at the Washington Marriott at Metro Center. This can’t-miss event will build upon the monumental success of CGIC2024 & will connect the dots across initiatives within C-Path’s portfolio.

How Individuals and Organizations Can Support TRxA? Watch! f.mtr.cool/jszwoxlgvh  #CPath's TRxA, is an accelerator focused on supporting academic scientists in advancing novel therapeutics from university labs to drug development pipelines.

Register Now for C-Path's 21ˢᵗ Century Trials in New-Onset Type 1 Diabetes Virtual Workshop! How the Use of C-Peptide can Accelerate the Development of Next-Gen Disease-Modifying Therapies for T1D.  Register now: f.mtr.cool/xfsxczbsyh #CPath20Years #T1D

C-Path’s International Neonatal Consortium and NANN are thrilled to announce the launch of FREE Neonatal #DrugDevelopment Modules for #NICU nurses and neonatal healthcare professionals. Earn CE hours! f.mtr.cool/gnmulavaza #CPath #drugdevelopment #regulatoryscience

CGIC24 Interview: Maaike Everts, Executive Director of TRxA at C-Path, speaks about TRxA, a pioneering initiative aimed at bridging the gap between basic research and clinical drug development. Watch here: f.mtr.cool/iitbflhlff

Interested in #CPath updates? Be sure to subscribe at f.mtr.cool/yrponekngf For 20 years, C-Path has been providing vital infrastructure to generate a neutral environment for everyone working in drug development to collaborate, not compete. Let's improve lives, together.

Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: f.mtr.cool/cqcszbaacx

In 2025, C-Path proudly celebrates 20 years of impact. Take a look back at the highlights and the incredible individuals who made it all possible. Here's to the next chapter of innovation! f.mtr.cool/gaaplfenqz #CPath20Years #DrugDevelopment #Collaboration

On Demand Now!  #CPath's TRxA BioBRIDGe Awards WEBINAR. Content includes an overview of the types of projects TRxA funds, eligibility criteria for BioBRIDGe awards, and details about how to apply. Watch here: f.mtr.cool/rcvpiaugew

CGIC24 Interview:  Jonathan Davis, MD, discusses the significant efforts and achievements of C-Path in collaboration with INC to improve drug development for preterm infants, a population that has been historically underserved. Watch here: f.mtr.cool/sxteleetxb

Join us for eCOA Exchange #4, the next offering in the eCOA Consortium’s eCOA Educational Series entitled eCOA: The Measure Owner's Perspective!  Register here: f.mtr.cool/bhngnofeei  📆 Tuesday May 6, 2025 ⏰ 11 - 11:55 a.m. Eastern (US)

SAVE THE DATE! 2025 C-Path Global Impact Conference (CGIC), scheduled for September 9-11, at the Washington Marriott at Metro Center. This can’t-miss event will build upon the monumental success of CGIC2024 & will connect the dots across initiatives within C-Path’s portfolio.

How Individuals and Organizations Can Support TRxA? Watch! f.mtr.cool/ydfssvomki  #CPath's TRxA, is an accelerator focused on supporting academic scientists in advancing novel therapeutics from university labs to drug development pipelines.

Register Now for C-Path's 21ˢᵗ Century Trials in New-Onset Type 1 Diabetes Virtual Workshop! How the Use of C-Peptide can Accelerate the Development of Next-Gen Disease-Modifying Therapies for T1D.  Register now: f.mtr.cool/kyusvpnkiv #CPath20Years #T1D

CGIC24 Interview: Nick King, Executive Director of the Predictive Safety Testing Consortium (PSTC), talks about PSTC’s primary aim in advancing regulatory acceptance for new biomarkers that can detect DIKI more effectively. Watch here: f.mtr.cool/oayvdpqqkh

C-Path’s International Neonatal Consortium and NANN are thrilled to announce the launch of FREE Neonatal #DrugDevelopment Modules for #NICU nurses and neonatal healthcare professionals. Earn CE hours! f.mtr.cool/ijzcwrnyqo #CPath #drugdevelopment #regulatoryscience

Interested in #CPath updates? Be sure to subscribe at f.mtr.cool/mvlhjvitqx For 20 years, C-Path has been providing vital infrastructure to generate a neutral environment for everyone working in drug development to collaborate, not compete. Let's improve lives, together.

Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: f.mtr.cool/nldcnxvuwd